Journals / Gülhane Tıp Dergisi / 2017 / Cilt: 59 - Sayı: 1

Assessment of a low ankle brachial index in young males with congenital hypogonadism

Konjenital hipogonadizm bulunan genç erkek hastalarda düşük ayak bileği kol indeksinin değerlendirilme

Pages
11–15
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

ABI measurement might not be a sensitive tool to detect PAD in young male patients with hypogonadism.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Cardio-metabolic diseases are prevalent in hypogonadism.
📊
Key Findings & Data:This study investigated whether young and treatment naïve hypogonadal patients had higher frequency of PAD and were under increased risk of systemic atherosclerosis.
💡
Conclusion & Impact:ABI measurement might not be a sensitive tool to detect PAD in young male patients with hypogonadism.
🔬Design:Modeling & Simulation
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Cardio-metabolic diseases are prevalent in hypogonadism. Peripheral arterial disease (PAD) is a manifestation of systemic atherosclerosis and is a well-known predictor of coronary heart disease and stroke. This study investigated whether young and treatment naïve hypogonadal patients had higher frequency of PAD and were under increased risk of systemic atherosclerosis. The study included 49 patients with congenital hypogonadotrophic hypogonadism (CHH) (mean age: 21.82 ± 2.28 years) and 37 healthy control subjects (mean age: 22.34 ± 1.20 years). Blood asymmetric dimethylarginine (ADMA) and high-sensitivity C-reactive protein (hs-CRP) were measured, and insulin resistance was calculated using homeostatic model assessment of insulin resistance (HOMA-IR) score. PAD was determined by the ankle brachial index (ABI) using Doppler technique. Patients with CHH had higher total cholesterol (p=0.038), triglyceride (p=0.047), insulin (p<0.001), HOMA-IR score (p<0.001) and ADMA (p<0.001), and lower body mass index (p=0.001) and systolic blood pressure (p<0.007), compared to healthy controls. Mean ABI value was 1.05 ± 0.13 in patients and 1.00 ± 0.10 in controls (NS). Based on a low ABI, 12.2% of patients and 13.5% of controls had lower extremity PAD (NS). However, in the multivariable model none of the study parameter was a predictor of a low ABI. Young and treatment naive patients with CHH had increased dysmetabolic features such as endothelial dysfunction and insulin resistance but did not have increased frequency of a low ABI compared to controls. ABI measurement might not be a sensitive tool to detect PAD in young male patients with hypogonadism.

Özet

Konjenital hipogonadizm bulunan genç erkek hastalarda düşük ayak bileği kol indeksinin değerlendirilmesiKardiyometabolik hastalık sıklığı hipogonadizmde artmıştır. Periferik arter hastalığı (PAH) sistemik aterosklerozun bir manifestasyonu olup koroner arter hastalığı ve inme açısından iyi bir öngördürücüdür. Bu çalışmada tedavi almamış genç hipogonad hastalarda PAH sıklığının artıp artmadığı ve bu hastaların sistemik ateroskleroz açısından artmış riske sahip olup olmadıkları araştırılmıştır. Çalışmaya 49 konjenital hipogonadotropik hipogonadizm (KHH) hastası (ort. yaş: 21.82 ± 2.28 yıl) ve 37 sağlıklı olgu (ort. yaş: 22.34 ± 1.20 yıl) dahil edildi. Hasta ve sağlıklı kontrollerde plazma asimetrik dimetilarjinin (ADMA) ve yüksek duyarlılıklı C-reaktif protein (hs-CRP) düzeyleri ölçüldü. İnsülin direnci, homeostatic model assessment of insulin resistance (HOMA-IR) yöntemi ile hesaplandı. PAH, Doppler tekniği kullanılarak ölçülen ayak bileği kol indeksine (ABI) göre belirlendi. KHH hastalarında, sağlıklı kontrollerle karşılaştırıldığında daha yüksek total kolesterol (p=0.038), trigliserid (p=0.047), insulin (p<0.001), HOMA-IR skoru (p<0.001) ve ADMA (p<0.001) düzeyleri ve daha düşük vücut kitle indeksi (p=0.001) ve sistolik kan basıncı (p<0.007) düzeyleri tespit edildi. Ortalama ABI değerleri hastalarda 1.05 ± 0.13 ve sağlıklı kontrollerde 1.00 ± 0.10 (NS) olarak bulundu. Düşük ABI değerleri açısından bakıldığında hastaların %12.2'sinde ve kontrollerin %13.5'inde alt ekstremite PAH tespit edildi (NS). Bununla birlikte, regresyon analizinde çalışma parametrelerinin hiçbirinin düşük ABI düzeylerini predikte etmediği bulundu. Genç ve tedavi almamış KHH hastaları sağlıklı kontrollerle karşılaştırıldığında, endotheliyal disfonksiyon ve insulin direnci gibi metabolik bozukluklar açısından artmış riske sahip oldukları tespit edilirken düşük ABI açısından anlamlı farklılık tespit edilmedi. ABI ölçümü hipogonadizm bulunan genç erkeklerde PAH tespiti açısından duyarlı bir yöntem olmayabilir

🔖

Cite This Article

HAYMANA, C., AYDOĞDU, A., TAŞÇI, İ., SAFER, U., IBRAHİMOV, T., MERİÇ, C., KARA, K., AZAL, Ö., DİNÇ, M., YEŞİLDAL, F., TAPAN, S. (2017). Assessment of a low ankle brachial index in young males with congenital hypogonadism. Gülhane Tıp Dergisi, Cilt: 59 - Sayı: 1, 11–15. https://ajindex.com/articles/178141

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (13)

  1. Traish AM, Saad F, Feeley RJ, Guay A. The dark side of testosterone deficiency: III. Cardiovascular disease. J Androl 2009; 30(5): 477-494
  2. Kupelian V, Page ST, Araujo AB, Travison TG, Bremner WJ, McKinlay JB. Low sex hormone-binding globulin, total testosterone, and symptomatic androgen deficiency are associated with development of the metabolic syndrome in nonobese men. J Clin Endocrinol Metab 2006; 91(3): 843-850
  3. Stellato RK, Feldman HA, Hamdy O, Horton ES, McKinlay JB. Testosterone, sex hormone-binding globulin, and the development of type 2 diabetes in middle-aged men: prospective results from the Massachusetts male aging study. Diabetes Care 2000; 23(4): 490-494
  4. Akishita M, Hashimoto M, Ohike Y, et al. Low testosterone level is an independent determinant of endothelial dysfunction in men. Hypertens Res 2007; 30: 1029- 1034
  5. Dandona P, Dhindsa S, Chandel A, Chaudhuri A. Hypogonadotropic hypogonadism in men with type 2 diabetes. Postgrad Med 2009; 121(3): 45-51
  6. Traish AM, Saad F and Guay AT. The dark side of testosterone deficiency: II. Type 2 diabetes and insulin resistance. J Androl 2009; 30: 23-32
  7. Paraskevas KI, Mukherjee D, Whayne TF, Jr. Peripheral arterial disease: implications beyond the peripheral circulation. Angiology 2013; 64(8): 569-571
  8. Murabito JM, Evans JC, Larson MG, Nieto K, Levy D, Wilson PW. The ankle-brachial index in the elderly and risk of stroke, coronary disease, and death: the Framingham Study. Arch Intern Med 2003; 163(16): 1939- 1942
  9. Newman AB, Shemanski L, Manolio TA, et al. Anklearm index as a predictor of cardiovascular disease and mortality in the Cardiovascular Health Study. The Cardiovascular Health Study Group. Arterioscler Thromb Vasc Biol 1999; 19(3): 538-545
  10. Criqui MH, Denenberg JO. The generalized nature of atherosclerosis: how peripheral arterial disease may predict adverse events from coronary artery disease. Vasc Med 1998; 3(3): 241-245
  11. Ridker PM, Cushman M, Stampfer MJ, Tracy RP, Hennekens CH. Plasma concentration of C-reactive protein and risk of developing peripheral vascular disease. Circulation 1998; 97(5): 425-428
  12. Veves A, Akbari CM, Primavera J, et al. Endothelial dysfunction and the expression of endothelial nitric oxide synthetase in diabetic neuropathy, vascular disease, and foot ulceration. Diabetes 1998; 47(3): 457-463
  13. Sonmez A, Haymana C, Aydogdu A, et al. Endothelial dysfunction, insulin resistance and inflammation in congenital hypogonadism, and